TrimRx's Blog
Survodutide vs Wegovy: How They Compare on Weight and Liver Health
Survodutide and Wegovy both use the GLP-1 pathway to reduce appetite, but they aren’t in the same place. Wegovy (semaglutide) is FDA approved and…
Amycretin vs Wegovy: Should You Wait for the Next-Gen Drug?
If you’re choosing between starting Wegovy now and holding out for amycretin, here’s the honest framing. Wegovy is FDA approved, widely available, and backed…
Survodutide vs CagriSema: Two Investigational Obesity Drugs Compared
Survodutide and CagriSema are both investigational obesity drugs, but they come from different companies and use different hormone combinations. Survodutide (Boehringer Ingelheim and Zealand…
Amycretin vs CagriSema: How Novo Nordisk’s Two Next-Gen Obesity Drugs Compare
Amycretin and CagriSema are both Novo Nordisk obesity programs that pair GLP-1 with amylin, two appetite hormones, but they go about it differently. CagriSema…
Amycretin vs Retatrutide: How Two Next-Generation Weight Loss Drugs Compare
Amycretin and retatrutide are two of the most closely watched experimental obesity drugs in development, and they come from the two companies that already…
Survodutide vs Retatrutide: Dual vs Triple Agonist
Survodutide and retatrutide are both investigational obesity drugs that add glucagon to GLP-1, but retatrutide goes a step further by also targeting GIP. Neither…
Retatrutide vs CagriSema: How the Two Next-Gen Drugs Compare
Retatrutide and CagriSema are both investigational obesity drugs that outperform current medications in trials, and neither is FDA approved or available by prescription, from…
What Is Amycretin? The Next-Generation GLP-1 and Amylin Drug
Amycretin stands out for an unusual reason: it is one of the few high-efficacy obesity drugs being developed as both a weekly injection and…
CagriSema vs Wegovy: How They Compare
CagriSema and Wegovy share an active ingredient, which makes this an unusually direct comparison. CagriSema is Wegovy’s semaglutide plus a second drug, the amylin…
